Trade Mark Journal No.2026/028 10 July 2026
WO0000001924665 (42)
Office of origin: Germany
Date of International Registration:30 April 2026
Date of designation in the UK:
30 April 2026
International priority date claimed: 6 November 2025
(Germany)
- Class 42
- Biological research, clinical research and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development services in the field of gene therapy; testing services in the field of antibodies; testing services for vaccines and medicines; research and development in the field of cell therapies; testing services for gene or cell therapies.
Merck KGaA